| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
From the Departments of Central Nervous System/Alzheimer Disease* and Functional Genomics, Aventis-Pharma Paris Research Center, Vitry sur Seine, France; INSERM U422, Groupe Vieillissement Cérébral et Degenerescence Neuronale, Equipe Proteomique, Lille, France; UMR8525,|| Centre National de la Recherche Scientifique, Institut de Biologie de Lille, Université de Lille II, Lille, France; the Department of Psychiatry, Division of Neurobiology, Saarland University, Homburg/Saar, Germany; and the Department of Psychiatry and Neuropsychology,¶ Division of Cellular Neuroscience, Maastricht University, Maastricht, The Netherlands
Alzheimer’s disease (AD) is characterized by a substantial degeneration of pyramidal neurons and the appearance of neuritic plaques and neurofibrillary tangles. Here we present a novel transgenic mouse model, APPSLPS1KI that closely mimics the development of AD-related neuropathological features including a significant hippocampal neuronal loss. This transgenic mouse model carries M233T/L235P knocked-in mutations in presenilin-1 and overexpresses mutated human ß-amyloid (Aß) precursor protein. Aßx-42 is the major form of Aß species present in this model with progressive development of a complex pattern of N-truncated variants and dimers, similar to those observed in AD brain. At 10 months of age, an extensive neuronal loss (>50%) is present in the CA1/2 hippocampal pyramidal cell layer that correlates with strong accumulation of intraneuronal Aß and thioflavine-S-positive intracellular material but not with extracellular Aß deposits. A strong reactive astrogliosis develops together with the neuronal loss. This loss is already detectable at 6 months of age and is PS1KI gene dosage-dependent. Thus, APPSLPS1KI mice further confirm the critical role of intraneuronal Aß42 in neuronal loss and provide an excellent tool to investigate therapeutic strategies designed to prevent AD neurodegeneration.
This article has been cited by other articles:
 |
|
 |
|
  K. Iijima-Ando, S. A. Hearn, L. Granger, C. Shenton, A. Gatt, H.-C. Chiang, I. Hakker, Y. Zhong, and K. Iijima Overexpression of Neprilysin Reduces Alzheimer Amyloid-{beta}42 (A{beta}42)-induced Neuron Loss and Intraneuronal A{beta}42 Deposits but Causes a Reduction in cAMP-responsive Element-binding Protein-mediated Transcription, Age-dependent Axon Pathology, and Premature Death in Drosophila J. Biol. Chem., July 4, 2008; 283(27): 19066 - 19076. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K.-H. Sun, Y. de Pablo, F. Vincent, E. O. Johnson, A. K. Chavers, and K. Shah Novel Genetic Tools Reveal Cdk5's Major Role in Golgi Fragmentation in Alzheimer's Disease Mol. Biol. Cell, July 1, 2008; 19(7): 3052 - 3069. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Belinson, D. Lev, E. Masliah, and D. M. Michaelson Activation of the Amyloid Cascade in Apolipoprotein E4 Transgenic Mice Induces Lysosomal Activation and Neurodegeneration Resulting in Marked Cognitive Deficits J. Neurosci., April 30, 2008; 28(18): 4690 - 4701. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. He, Z. Zhong, K. Lindholm, L. Berning, W. Lee, C. Lemere, M. Staufenbiel, R. Li, and Y. Shen Deletion of tumor necrosis factor death receptor inhibits amyloid {beta} generation and prevents learning and memory deficits in Alzheimer's mice J. Cell Biol., August 27, 2007; 178(5): 829 - 841. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Vingtdeux, M. Hamdane, A. Loyens, P. Gele, H. Drobeck, S. Begard, M.-C. Galas, A. Delacourte, J.-C. Beauvillain, L. Buee, et al. Alkalizing Drugs Induce Accumulation of Amyloid Precursor Protein By-products in Luminal Vesicles of Multivesicular Bodies J. Biol. Chem., June 22, 2007; 282(25): 18197 - 18205. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. V. Zerbinatti, S. E. Wahrle, H. Kim, J. A. Cam, K. Bales, S. M. Paul, D. M. Holtzman, and G. Bu Apolipoprotein E and Low Density Lipoprotein Receptor-related Protein Facilitate Intraneuronal Abeta42 Accumulation in Amyloid Model Mice J. Biol. Chem., November 24, 2006; 281(47): 36180 - 36186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. C. Cruz, D. Kim, L. Y. Moy, M. M. Dobbin, X. Sun, R. T. Bronson, and L.-H. Tsai p25/Cyclin-Dependent Kinase 5 Induces Production and Intraneuronal Accumulation of Amyloid beta In Vivo J. Neurosci., October 11, 2006; 26(41): 10536 - 10541. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Oakley, S. L. Cole, S. Logan, E. Maus, P. Shao, J. Craft, A. Guillozet-Bongaarts, M. Ohno, J. Disterhoft, L. Van Eldik, et al. Intraneuronal beta-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation J. Neurosci., October 4, 2006; 26(40): 10129 - 10140. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Magrane, K. M. Rosen, R. C. Smith, K. Walsh, G. K. Gouras, and H. W. Querfurth Intraneuronal {beta}-Amyloid Expression Downregulates the Akt Survival Pathway and Blunts the Stress Response J. Neurosci., November 23, 2005; 25(47): 10960 - 10969. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Piccini, C. Russo, A. Gliozzi, A. Relini, A. Vitali, R. Borghi, L. Giliberto, A. Armirotti, C. D'Arrigo, A. Bachi, et al. {beta}-Amyloid Is Different in Normal Aging and in Alzheimer Disease J. Biol. Chem., October 7, 2005; 280(40): 34186 - 34192. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. P.F. Rutten, N. M. Van der Kolk, S. Schafer, M. A.M.J. van Zandvoort, T. A. Bayer, H. W.M. Steinbusch, and C. Schmitz Age-Related Loss of Synaptophysin Immunoreactive Presynaptic Boutons within the Hippocampus of APP751SL, PS1M146L, and APP751SL/PS1M146L Transgenic Mice Am. J. Pathol., July 1, 2005; 167(1): 161 - 173. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
